Ayala Pharmaceuticals Inc (fka ADXS)

[mypekeispooped]

I think you hit the nail on the head with many of your points here. I do believe we've had some excellent data in the HER2 trial for canines. I think any time you can double the OS of any group, it's a big win. Why BP wasn't all over this trying to buy it is beyond me. I DO think, once Aratana gets full approval for the vaccine, it will cause BP to look again at Advaxis. If the results can be replicated in children, than we will have a winner. The canine trial did not combine with a checkpoint inhibitor. I imagine in certain subgroups we may even see better results. All the missteps so far (and there have been many) rest on management's shoulders and I think the company is at a crossroads. We need a big win soon.